0.33 (-%)
As of Nov 20, 2024
Source:
Glycomimetics Inc is a late clinical-stage biotechnology company focused on improving the lives of people living with cancer and inflammatory diseases by leveraging the inhibition of carbohydrate interactions that occur on the surface of cells.
| Country | United States |
| Headquarters | rockville, maryland |
| Phone Number | (240) 243-1201 |
| Industry | manufacturing |
| CEO | Harout Semerjian |
| Website | www.glycomimetics.com |